What is the current stock price of BiondVax Pharmaceuticals Ltd. (BVXV)?

As of the latest market data, BiondVax Pharmaceuticals Ltd. (BVXV) is trading at $1.36. The stock has seen a gain of 0.74% today.

Does BiondVax Pharmaceuticals Ltd. (BVXV) pay a dividend?

Based on current data, BiondVax Pharmaceuticals Ltd. does not have a confirmed active dividend policy.

What is the market cap of BiondVax Pharmaceuticals Ltd.?

The current market capitalization of BiondVax Pharmaceuticals Ltd. (BVXV) is approximately unavailable.

BVXV

BiondVax Pharmaceuticals Ltd.·Healthcare

1.36

0.741%(+0.01)

Market Closed

Last Updated: — ET

52W L: $0.6352W H: $11.49

Company Profile

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2015-05-12

Beta

2.37

Websitewww.biondvax.com↗